CHUV-clinical research center
Lausanne, Canton of Vaud, CH-1011, Switzerland
NCT Number: NCT02747446
The metabolic effects of 7-day weight-maintenance diets containing 10% total energy as acacia honey or a fructose:glucose mixture will be assessed in a group of healthy male volunteers. Primary outcome is plasma total triglyceride concentrations after ingestion of standardized breakfast and lunch containing 25% energy as honey or fructose:glucose mixture; secondary outcome is glucose tolerance and suppression of endogenous glucose production after ingestion of 75 g glucose. Results obtained with 10% honey and 10% fructose: glucose mixture diets will be compared to results obtained with a weight-maintenance, isocaloric diet in which starch is substituted for honey or fructose:glucose mixture
Looking for future studies?
Notify Me18 year–30 year
Male
Interventional
Not applicable
Lausanne, Canton of Vaud, CH-1011, Switzerland
Eight health males volunteers will be studied three times in a randomized order
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
isocaloric substitution of added sugars (honey or FG) for starch
Time frame: 7-day dietary intervention
plasma triglyceride concentrations measured before and after ingestion of a breakfast and a lunch
Time frame: 7-day dietary intervention
plasma glucose and insulin concentration and suppression of endogenous glucose production after ingestion of 75 g glucose
Luc Tappy, MD
Other
Effects of a Dietary Honey or Isomolar Fructose:Glucose Mixture on Glucose Tolerance and Blood Lipid Profile in Healthy Male Volunteers
Acronym: HONEY
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial DetailsNCT06702423
Healthy
London, United Kingdom
View Trial DetailsNCT07223164
Healthy
Irvine, California, United States
View Trial DetailsNCT05595902
Healthy
Kadıköy, Istanbul, Turkey (Türkiye)
View Trial Details